Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Steatosis of the liver means an imaging scan such as ultrasound, CT, or MRI detected excess fat stored in your liver cells, a common finding that ranges from mild and reversible to more serious inflammation or scarring. Causes include metabolic factors like insulin resistance, obesity, high triglycerides, and type 2 diabetes, as well as alcohol use, certain medications, rapid weight loss, and some viral infections. Grading (mild, moderate, or severe) and follow-up tests like liver enzymes, FibroScan, or a fibrosis score determine whether the fat has progressed to steatohepatitis or fibrosis, and several important factors affect your risk, so see below to understand more.
Because fatty liver often causes no symptoms until damage advances, subtle signs such as fatigue, upper right abdominal discomfort, or unexplained weight changes are worth evaluating sooner rather than later. Take a free, instant, online symptom check to see how your symptoms and risk factors fit together and to get clear guidance on which next steps and specialists make sense for you.
Last reviewed for medical accuracy: 09/28/2026
Steatosis of the Liver: What Fatty Liver on a Scan Means
Steatosis of liver—often called “fatty liver”—occurs when excess fat builds up in liver cells. It’s a common finding on ultrasound, CT or MRI scans. While mild steatosis of liver may cause no symptoms, understanding what it means and how to manage it can help protect long-term liver health.
What Is Steatosis of Liver?
Steatosis refers to fat droplets accumulating inside hepatocytes (liver cells). Normally, the liver contains a small amount of fat. When fat exceeds 5–10% of liver weight, it’s classified as steatosis. There are two main types:
How Is Fatty Liver Detected?
Most people with steatosis of liver have no obvious signs. It’s usually picked up incidentally during imaging or routine blood tests. Detection methods include:
Common Risk Factors
Several factors increase the risk of developing steatosis of liver:
Potential Symptoms and Complications
Most people with simple steatosis of liver feel well. However, some may notice:
It’s important to identify and address risk factors early to prevent progression.
Diagnosis and Assessment
After imaging suggests steatosis of liver, your doctor may recommend:
These tests help gauge whether simple fat accumulation has progressed to more serious injury.
Managing Steatosis of Liver
There’s no specific medication approved for reversing fatty liver. Management focuses on lifestyle changes and controlling underlying conditions:
Lifestyle Modifications
• Weight loss: A 5–10% reduction in body weight can significantly reduce liver fat.
• Diet:
– Emphasize fruits, vegetables, whole grains, lean proteins.
– Limit added sugars, refined carbs, saturated fats.
– Mediterranean-style diet shows benefit.
• Exercise:
– At least 150 minutes of moderate aerobic activity per week (brisk walking, cycling).
– Strength training twice weekly.
• Alcohol:
– Avoid or limit intake. Even moderate drinking may worsen liver health.
Medical Management
• Control diabetes, high blood pressure, high cholesterol.
• Statins and antidiabetic drugs (e.g., pioglitazone, GLP-1 agonists) may help in select cases—discuss options with your doctor.
Regular Monitoring
• Repeat liver enzyme tests every 6–12 months.
• Follow-up imaging or elastography if fibrosis risk is high.
When to Seek Help
Steatosis of liver itself rarely causes emergencies. But worsening liver health can lead to serious complications. Seek medical attention if you experience:
If symptoms seem life threatening or progress rapidly, call emergency services immediately.
Preventing Progression
Early intervention can halt or reverse liver fat accumulation:
Considering Your Symptoms
If you’ve noticed fatigue, unexplained discomfort, or have risk factors for steatosis of liver, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you understand possible causes of your symptoms and guide you toward next steps.
Living Well with Steatosis of Liver
Most people with early steatosis of liver lead full, active lives. Key strategies for long-term health:
When to Talk to Your Doctor
Always consult a healthcare provider for personalized advice. Discuss any new or worsening symptoms, treatment side effects, or questions about medications. If you suspect serious liver problems—or any life-threatening condition—seek medical attention without delay.
Summary
Steatosis of liver means fat buildup in liver cells. It’s often silent but can progress to inflammation, fibrosis and cirrhosis. Early detection through imaging and blood tests, combined with lifestyle changes and management of related conditions, can reverse or stabilize liver health. Regular monitoring and collaboration with your healthcare team are essential.
Remember: if you have concerns about steatosis of liver or related symptoms, talking to a doctor is the best way to get clear guidance and peace of mind.
(References)
* Sherer DM, Abramowicz JS. Magnetic resonance imaging and computed tomography scan for the diagnosis of acute fatty liver in pregnancy. Am J Perinatol. 1992 Jul;9(4):311. PMID: 1627228.
* Chudácek Z. [Focal steatosis]. Bildgebung. 1990;57(1-2):32-4. PMID: 2271812.
* CAMAIN R, ROUILLER C, DUPIN H. [Development of hepatic steatosis in kwashiorkor treated by hyperprotein diet; simple & electron microscopic study]. Ann Anat Pathol (Paris). 1959 Apr-Jun;4(2):220-41. PMID: 13650240.
* Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28. PMID: 24459637; PMCID: PMC3894432.
* Walker AP. Ischaemic stroke and liver fibrosis. Atherosclerosis. 2017 May;260:153-155. doi: 10.1016/j.atherosclerosis.2017.03.028. Epub 2017 Mar 22. PMID: 28359541.
* Yang M, Hara AK, Nguyen BD, Roarke MC. Concurrent focal fat sparing and peritumoral fat sparing in diffuse fatty liver identified on 18F-FDG PETCT and multiparametric magnetic resonance imaging. Dig Liver Dis. 2017 Oct;49(10):1164. doi: 10.1016/j.dld.2017.04.019. Epub 2017 May 27. PMID: 28600027.
* Schaapman JJ, Coenraad MJ, Lamb HJ. Response to letter: Multiparametric magnetic resonance imaging in patients with nonalcoholic fatty liver disease. J Magn Reson Imaging. 2021 Jun;53(6):1941. doi: 10.1002/jmri.27510. Epub 2021 Jan 12. PMID: 33438298.
* Chen SQ, He K, Xiao XL. Multifocal nodular fatty infiltration of the liver: A donut-shaped appearance. Clin Res Hepatol Gastroenterol. 2022 Aug-Sep;46(7):101985. doi: 10.1016/j.clinre.2022.101985. Epub 2022 Jun 21. PMID: 35738358.
* Meria A, Meria P. Re: What Is the Prevalence of Hepatic Steatosis on Ultrasonography in Patients Followed for Nephrolithiasis? Eur Urol. 2023 Sep;84(3):352-353. doi: 10.1016/j.eururo.2023.05.007. Epub 2023 May 22. PMID: 37225527.
* Tokcan M, Hohl M, Schneider CV, Schneider KM, Markwirth P, Bernhard B, Haring B, Lauder L, Schattenberg J, Mahfoud F, Kulenthiran S, Böhm M. Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome. Hypertension. 2026 Apr;83(4):e26601. doi: 10.1161/HYPERTENSIONAHA.125.26601. Epub 2026 Feb 24. PMID: 41732855; PMCID: PMC13001895.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.